Innoviva Inc at Goldman Sachs Healthcare Conference Transcript
All right. Terrific. Let's go right into our next session. I am very pleased to have Pavel Raifeld, CEO of Innoviva Pharmaceuticals. Pavel, thank you so much for being with us for the afternoon session.
Questions & Answers
So maybe, Pavel, just for investors listening on the webcast and those online and maybe those for those not pretty familiar with the story, let's just start to level set with a little bit of a brief evolution of the company, it's colpillars and what your view makes in Innoviva different.
Perfect. Asad, thank you very much. It's a pleasure to be here, and I appreciate an opportunity to attend the conference. So I think that Innoviva is a somewhat usual -- is some of the usual company. And our routes are that -- a number of years ago, we invented the technology that's being used in some of the most commonly used stand COPD treatments,
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
